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Deregulated cellular signalling is a common hallmark of disease, and delineating tissue 
phosphoproteomes is key to unravelling the underlying mechanisms. Here we present the 
broadest tissue catalogue of phosphoproteins to date, covering 31,480 phosphorylation sites 
on 7,280 proteins quantified across 14 rat organs and tissues. We provide the data set as an 
easily accessible resource via a web-based database, the CPR PTm Resource. A major fraction 
of the presented phosphorylation sites are tissue-specific and modulate protein interaction 
networks that are essential for the function of individual organs. For skeletal muscle, we find 
that phosphotyrosines are over-represented, which is mainly due to proteins involved in 
glycogenolysis and muscle contraction, a finding we validate in human skeletal muscle biopsies. 
Tyrosine phosphorylation is involved in both skeletal and cardiac muscle contraction, whereas 
glycogenolytic enzymes are tyrosine phosphorylated in skeletal muscle but not in the liver. The 
presented phosphoproteomic method is simple and rapid, making it applicable for screening of 
diseased tissue samples. 
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Protein phosphorylation is a post-translational modification implicated in a diverse variety of cellular processes, span-ning from proliferation and differentiation to apoptosis. Site- 
specific phosphorylation events can function as molecular switches 
that either activate or inhibit protein activity, dictate sub-cellular 
localization or act as recruitment platforms for interacting proteins 
with special domains (such as SH2, PTB, BRCT, 14-3-3 and FHA 
domains). Cellular protein phosphorylation is tightly controlled 
by protein kinases and phosphatases, and as these enzymes have 
differential expression levels across tissues, protein phosphoryla-
tions are dynamic events with restricted spatial and temporal dis-
tribution. The activity of kinases and phosphatases are themselves 
fine-tuned by phosphorylation events, thereby interconnecting 
signalling pathways outlining a complex regulatory pattern. Phos-
phorylation events have been implicated in the pathophysiology of 
several severe diseases, such as cancer, diabetes and neuropsychi-
atric disorders1–6. For instance, in leukemia, activating mutations 
in kinases such as flt3 (ref. 7) and bcr-abl8 are often the oncogenic 
drivers of cell transformation. The fact that deregulated signalling is 
a hallmark of many diseases highlights the importance of develop-
ing techniques that allow for rapid, comprehensive and quantitative 
determinations of tissue phosphoproteomes.
Quantitative mass spectrometry (MS)-based phosphoproteom-
ics is currently the most powerful technique for analysis of cellular 
signalling networks9. Advances of the methodology have mainly 
been driven by the introduction of robust methods for phosphopep-
tide enrichment10–12 in combination with stable isotope labelling 
techniques13,14 and high-resolution hybrid mass spectrometers15. 
We and others have previously described methods to study global 
phosphorylation site changes as a function of specific stimuli16–19. 
However, these investigations were typically the results of huge 
efforts requiring hundreds of hours of mass spectrometric analysis 
and were all conducted in cell lines. So far, there have only been 
limited attempts to analyse phosphoproteomes of tissues and organs 
on a systems-wide scale20–23. Such attempts have all been based on 
extensive fractionation by ion-change chromatography to reduce 
sample complexity and low-resolution tandem MS, necessitating 
days of mass-spectrometric measurement time per tissue sample. 
Rodent models exist for many human signalling diseases and to 
date phosphoproteomes of nine mouse tissues has been analyzed 
in-depth20. However, the rat has important advantages relative to 
mouse for the study of cardiovascular diseases, diabetes, arthritis 
and many autoimmune, neurological, behavioural and addiction 
disorders24 as well as for testing pharmacodynamics and toxicity 
of potential therapeutic compounds25. Therefore, we aimed 
to quantify the rat organ phosphoproteome in an in-depth and 
reproducible manner.
Here we quantitatively map phosphoproteomes of 14 rat tis-
sues and present a large data set of 31,480 phosphorylation sites 
from 7,280 proteins as a resource to the scientific community. We 
combine an effective tissue phosphoproteome preservation and 
homogenization protocol with a simple, single-step phosphopep-
tide enrichment method followed by higher-energy collisional 
dissociation (HCD) fragmentation26 on an LTQ-Orbitrap Velos 
instrument27. This approach allows for in-depth investigation of 
tissue phosphoproteomes in single-shot liquid chromatography 
(LC)-MS analyses using a gradient of just 3 h, thus significantly 
reducing the time required for determination of a tissue phospho-
proteome. In addition, HCD provides higher data quality cover-
ing the full mass region without a low-mass cut-off combined with 
high-resolution and accurate mass fragment ion measurements, 
which makes it a potent fragmentation technique for phosphopep-
tides28. Further underscoring the general applicability and transla-
tional aspects of the developed method, we validate the rat skeletal 
muscle phosphoproteome in human skeletal muscle biopsies. For 
each tissue, we systematically analyse the physical interactions of 
phosporylated proteins in silico to generate first drafts of spatial 
molecular networks regulated by tissue-specific phophatase and 
kinase dynamics.
Results
Phosphoprotein identification from 14 rat tissues. To investigate 
phosphoproteins across tissues, organs were harvested from Sprague 
Dawley albino rats (Crl:SD) and they were all immediately snap 
frozen. We pooled organs from four rats to account for biological 
variation. The tissues isolated were: brain (dissected into cerebellum, 
cortex and brainstem), heart, muscle, lung, kidney, liver, stomach, 
pancreas, spleen, thymus, perirenal fat, intestine, testis and blood 
(Fig. 1). To preserve the in-vivo state of the phosphoproteome 
and reduce post-mortem effects in dissected tissue samples, we 
eliminated endogenous enzymatic activity by thermal protein 
denaturation of the snap frozen samples using a Stabilizor T1 
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Figure 1 | Workflow for phosphoproteome analysis of rat tissue. A total 
of 14 different tissues were isolated from four male rats, followed by snap 
freezing, homogenization and solubilization of the tissues. For each tissue, 
10 mg of protein was subjected to tryptic digestion, succeeded by duplicate 
steps of phosphopeptide enrichments using titanium dioxide beads. Both 
enrichments were analysed by high-resolution LC-ms/ms yielding a total 
of 31,480 phosphorylation sites.
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(Denator, Sweden). This procedure effectively abolish the activity 
of protein phosphatases, kinases, proteases and other enzymes that 
can change the protein modification site abundance during sample 
handling29. Next, we carefully homogenized the tissues in a urea 
buffer using ceramic beads on a Precellys 24 (Bertin Technologies, 
France). Following brief sonication, protein concentration was 
determined and from each tissue extract 10 mg protein was digested 
in solution with endoproteinase Lys-C and trypsin. Two rounds of 
phosphopeptide enrichment by titanium dioxide chromatography 
were performed, and the enriched phosphopeptide fractions were 
analysed by 3 h LC-MS gradients on a high-performance LTQ 
Orbitap Velos mass spectrometer, where all tandem mass spectra 
were recorded in the orbitrap analyser with high-resolution using the 
HCD technology. All LC-MS/MS raw files were processed together, 
peptide sequences were identified by Mascot and phosphoproteins 
were quantified using the MaxQuant software suite’s label-free 
algorithm based on peptide extracted ion chromatograms. All raw 
files and annotated MS/MS spectra are provided as a resource (see 
Supplementary Data 1). In total, 876,203 high-resolution HCD-
MS/MS events were collected of which 43% were identified with 
high confidence, which resulted in 28,733 unique phosphopeptides 
corresponding to 31,480 phosphorylation sites from 7,280 proteins. 
Tables with all identified phosphoproteins and phosphopeptides are 
provided in Supplementary Data 1–4, and evaluation of the high-
quality MS data is shown in Supplementary Fig. S1. Furthermore, we 
have set up a web-accesible MySQL database named the CPR PTM 
Resource containing all identified phosphoproteins making it easy 
to search for identified phosphorylation sites on any given protein of 
interest: http://cpr1.sund.ku.dk/cgi-bin/PTM.pl. The confidence of 
phosphorylation site localization was evaluated for each site on every 
phosphopeptide and for annotation of a specific phosphorylation 
site a localization score ≥75% combined with a ∆PTM ≥5 was 
required. More than 70% of the sites we identified localized to a 
specific amino acid with a median localization score  > 99.9%. Thus, 
the combination of an efficient protein extraction procedure with 
high-accuracy mass spectrometric measurements allowed us to 
identify a large number of phosphorylation sites in a very limited 
time frame. The method outlined makes it possible to determine a 
tissue phosphoproteome in less than 2 days.
Phosphoprotein expression pattern across tissues. We first focused 
on the phosphoproteins identified in each LC-MS run and used 
normalized phosphoprotein intensities derived from summation of 
measured phosphopeptide extracted ion chromatograms to perform 
a comparative analysis. Hierarchical cluster analysis visualizes the 
experimental specificity and reproducibility (Fig. 2a). Reassuringly, 
the duplicate enrichments from each tissue cluster together, as does 
functionally related tissues, as for instance heart and muscle and the 
three brain regions investigated. Phosphoproteins are colour coded 
according to their MS signal intensities, which is a relative measure 
for protein abundance30,31, and the highlighted yellow areas thus 
indicate that the majority of tissues have abundant expression of a 
specific cluster of phosphoproteins. It is evident that the identified 
phosphoproteins vary in expression pattern as well as in phosphor-
ylation site abundance among the tissues reflecting the physiological 
differences of the tissues. A few clusters of phosphoproteins are 
Low High
Musc
leHe
art
Panc
reas
Testi
s
Splee
n/thym
us/
lung
Perir
ena
l FatS
toma
chKidne
yIntes
tineLive
rBlo
od
Brain
All
All
1,000
2,000
3,000
4,000T
ot
al
 #
 p
ho
sp
ho
pr
ot
ei
ns
Blood 2
Blood 1
M
uscle 2
M
uscle 1
H
eart 2
H
eart 1
Lung 2
Lung 1
Thym
us 1
Thym
us 2
Spleen 1
Spleen  2
Kidney 2
Kidney 1
Intestine 2
Intestine 1
Liver 2
Liver 1
Perirenal Fat 2
Perirenal Fat 1
Testis 1
Testis 2
Pancreas 1
Pancreas 2
Brainstem
 2
Brainstem
 1
Cerebellum
 2
Cerebellum
 1
Cortex 2
Cortex 1
Stom
ach 1
Stom
ach 2
Figure 2 | Tissue distribution of phosphoproteins. (a) Hierarchical clustering of phosphoproteins and tissues based on label-free quantification of protein 
intensities from both enrichment steps (1 and 2). Low-intensity phosphoproteins are depicted in blue and high-intensity phosphoproteins are depicted 
in yellow. Red boxes highlight clusters of phosphoproteins that are either specific to a certain tissue or present in all tissues. (b) Histograms depicting 
the total number of phosphoproteins identified from each of the two enrichment steps (shown in blue) as well as the total number of phosphoproteins 
identified in each tissue obtained from merging the data from the two enrichment steps (shown in grey).
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present in all tissues investigated, which is the pattern expected for 
instance for house-keeping proteins. Only few phosphoproteins 
identified in blood are also identified in other tissues, illustrating 
that our perfusion of the animals during euthanization was effective. 
The total number of phosphoproteins identified from each of the 
two enrichment steps is comparable within each tissue, but a slight 
gain in coverage is obtained with the second incubation resulting in 
an increased total number of phopshoproteins when merging the 
two data sets (Fig. 2b). For each tissue, the duplicate enrichments 
yield reproducible normalized phophopeptide intensity results 
with Pearson correlation coefficients in the range 0.77 < R < 0.90 
(see Supplementary Figs S2–S6), which indicates that the technical 
reproducibility is high and that the detected heterogeneity in num-
bers of phosphoproteins per tissue reflects a true biological varia-
tion. The obtained clustering profile of phosphoprotein expression 
underscores the robustness of the method and gene ontology (GO) 
enrichment analysis further confirms this. GO term analysis of tis-
sue-specific phosphoproteins reveal that these are indeed proteins 
with known tissue-specific roles, as for instance neuronal signalling 
regulation in brain and muscle contraction regulation in muscle and 
heart (Supplementary Fig. S7). Conversely, phosphoproteins found 
in all tissues are proteins known to be important for all cell types, as 
for instance RNA processes and transcription.
Tissue-specific interaction networks of phosphoproteins. To ana-
lyse the functions of the tissue-specific phosphoproteins further, we 
probed their molecular networks in silico. Such analyses are relevant 
as protein interaction networks with tissue resolution are valuable 
resources for deciphering and understanding the specific molecular 
systems driving pathological processes32,33. For each of the 14 tis-
sues, we generated protein interaction networks using the tissue-
specific phosphoproteins as seeds. Direct protein interactions, and 
indirect interactions through common interaction partners, were 
identified using a previously described database of quality control-
led predicted and measured protein interaction data32,34,35. The 
data quality thresholds were optimized by permutation tests, and 
a network-building algorithm35,36 was applied to build 14 protein 
interaction networks with tissue resolution. Eight of the fourteen 
networks interact significantly (1.0e-5 ≤adj. P≤0.049, adjusted for 
multiple testing by Bonferroni correction, Supplementary Data 5), 
indicating that tissue-specific phosphoproteins have a strong ten-
dency to directly interact, or are part of connected tissue-specific 
pathways. All networks are available in flat file format and in Cyto-
scape session format as a user-friendly community resource from 
http://cpr1.sund.ku.dk/cgi-bin/PTM.pl (see Supplementary Data 2). 
An example of a tissue-specific phosphoprotein network is shown 
in Fig. 3, which illustrates a network based on phosphoproteins 
specifically identified in blood. By manual curation the network 
was found to consist of relevant functional clusters, such as coagu-
lation, Kell blood group glycoprotein complex, haemoglobin and 
haem biosynthesis, inflammatory responses, immune regulation, 
and albumin-mediated transport. Our blood phosphoproteome is 
currently the largest phosphorylation data set measured from blood 
samples, and the protein interaction network expands our current 
understanding of the functional roles of phosphorylated proteins 
in blood37.
Tissue-specific versus globally expressed phosphoproteins. A 
larger proportion of the identified phosphoproteins are tissue spe-
cific than globally expressed (Fig. 4a), with 11.4% of the identified 
phosphoproteins being found in one tissue only and 5.4% being 
found in all tissues. To investigate global patterns for the biological 
roles of the tissue-specific versus the globally expressed phospho-
proteins, we made a GO term analysis comparing phosphoproteins 
found either in a single tissue or in all tissues to all other identi-
fied phosphoproteins (Fig. 4b). Globally expressed phosphoproteins 
are enriched for cytoplasmic and nuclear proteins involved in RNA 
processes, whereas tissue-specific phosphoproteins are enriched 
for plasma membrane proteins involved in ion transport and recep-
tor-triggered signalling events. These findings are consistent with 
our current understanding that a large fraction of intracellular com-
ponents are generic among cells, whereas specific cell types pre-
dominantly differ in the composition of proteins they expose at the 
plasma membrane38. Although we identify tissue-specific phospho-
proteins in all tissues, we observe a significantly higher number of 
tissue-specific phosphoproteins in brain and testis compared with 
the other tissues investigated (Supplementary Fig. S8), which is also 
consistent with data reported from mouse tissues20. This finding 
converges well with the GO term analysis in the sense that brain 
is expected to be the tissue investigated with the most diverse 
expression of ion channels and receptors and testis expresses many 
tissue-specific proteins.
To estimate whether the map of rodent protein phosphorylation 
sites is comprehensive, we merged the rat data set presented here 
with the recently published mouse phosphoproteome data set20. At 
the protein level, we find 51.5% overlap between the phosphopro-
teins reported here, and those reported for the mouse, and at the 
site level the overlap is 23.2% (Supplementary Fig. S9), thus indicat-
ing that the map is not yet comprehensive. Merging the two data 
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Figure 3 | Blood-specific phosphoprotein network. Protein interaction 
network based on phosphoproteins specifically identified in blood 
(green nodes) and expanded to include direct interaction partners (grey 
nodes). Protein clusters obviously relevant to blood biology, such as 
coagulation, Kell blood group glycoprotein complex, haemoglobin and 
haem biosynthesis, inflammatory responses, immune regulation and 
albumin-mediated transport, are highlighted. The network is available as a 
Cytoscape session file including accession numbers and protein names for 
all proteins in the network at http://cpr1.sund.ku.dk/cgi-bin/PTm.pl.
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sets result in a total of 9,287 rodent phosphoproteins harbouring 
an impressive 54,755 phosphorylation sites. This shows that phos-
phorylation is a post-translation modification with even more 
widespread impact on rodent proteins than previously estimated.
Tissue distribution of specific phosphorylation sites. In total, 
23,415 of the identified phosphorylations can be localized to a spe-
cific residue using combined cut-off values of localization probabil-
ity ≥0.75 and ∆PTM score ≥5, as previously described16. For each tis-
sue, we investigated the relative abundance of phosphorylation sites 
of serine, threonine and tyrosine residues, and on average we find 
that serines account for 88.1%, threonines for 11.4% and tyrosines 
for 1.5% of all phosphorylation sites (Fig. 5a), which is consistent 
with previously published observations16,20. As a number of serine/
threonine protein kinases are targeting specific sequence motifs, we 
used our data to evaluate the relative involvement of these kinases 
across tissues (Fig. 5b). As expected, we observe that basophilic 
kinases (PKA, PKD, AKT, CAMK2, AURORA and CHK) form a clus-
ter, and that the relative sequence motif abundances of the majority 
of these kinases are comparable across most tissues. However, motifs 
matching those recognized by PKD and CHK kinases are relatively 
more abundant in stomach than in any other tissue, as are ATM 
motifs in blood and PLK motifs in skeletal muscle. Likewise, we find 
that CK2 and AKT motifs are abundant in pancreas, which is in line 
with reports on the involvement of the AKT signalling pathway in 
pancreatic cancer3,39, and CK2 involvement in insulin regulation of 
pancreatic β-cells40. It is also noticeable that the three different brain 
regions investigated exhibit similar patterns, which is consistent with 
our finding that cerebellum, cortex and brainstem appear very simi-
lar at the phosphoproteome level (also see Fig. 2a).
As brain and testis have the greatest number of tissue-specific 
phosphoproteins, we investigated if there were any particular 
sequence motifs characteristic for the amino-acid sequences flank-
ing the serine and threonines residues phosphorylated in brain or 
testis (Fig. 5c). From the visualized consensus motifs, it is evident 
that proline-directed phosphorylation is prominent in brain tissue 
but not in testis, whereas acidophilic kinase directed phosphoryla-
tion, for example, CK2, is pronounced in brain as well as testis. 
We next analyzed the amino-acid sequences flanking tissue-spe-
cific phosphorylation sites versus the phosphorylation sites found 
in other tissues for brain and testis, respectively. We find a strong 
signal for proline-directed phosphorylation for brain-specific phos-
phorylation sites, and for both tissues we observe that the CK2 sub-
strate phosphorylation sites are not tissue specific. It thus appears 
that CK2-mediated phosphorylation in brain and testis is involved 
in regulation of proteins that are part of the general cellular machin-
ery, whereas proline-directed phosphorylation occurs on proteins 
characteristic for brain tissue.
Phosphorylation pattern in rat and human skeletal muscle. 
When analyzing the distribution of S, T and Y phosphorylation sites 
across tissues, it became evident that the only tissue exhibiting a 
different pattern compared with all other tissues was skeletal muscle 
(Fig. 5a). In rat muscle, we found phosphorylation of tyrosine resi-
dues to account for 3.9% of all phosphorylations, which is a signifi-
cant over-representation compared with the total average of 1.5% 
(P < 1.1e-8). Likewise, threonine sites account for 17.1% versus the 
tissue average of 11.4%. To investigate whether this pattern is a gen-
eral trend of physiological relevance, we decided to study the phos-
phorylation pattern in human skeletal muscle samples. We analysed 
skeletal muscle biopsies taken from three healthy male subjects, and 
investigated the phosphoproteomes from these according to the 
same protocol as for the rat tissues (all identified phosphoproteins 
and phosphopeptides are provided in Supplementary Data 6). The 
human skeletal muscle phosphoproteomes resemble the phospho-
proteome from rat skeletal muscle (see Supplementary Fig. S10a–b), 
and our results from human muscle confirm the trend observed in 
rat muscle. In human skeletal muscle, tyrosine phosphorylation 
account for 4.3% and threonine for 14.2% of all phosphorylations 
(Fig. 5a). When analysing the sequence patterns flanking the serine 
and threonine phosphorylations identified in rat or human skeletal 
muscle samples and comparing these to the sequences found in all 
other tissues, we, as expected, find that threonine phosphoryla-
tions are over-represented, but we also find that proline-directed 
phosphorylation is greatly under-represented in muscle compared 
with all other tissues. When we compare the muscle-specific serine 
or threonine phosphorylation sites against the sites that are also 
found in other tissues, we again, as in brain and testis, find that 
CK2-mediated phosphorylation is over-represented for the sites 
that are not tissue-specific. For the muscle-specific phosphorylation 
sites there are no apparent consensus sequence, but there seems to 
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be a preference for lysine and hydrophobic residues flanking the 
phosphorylation site (Supplementary Fig. S10c). To investigate the 
physiology underlying the over-representation of phosphotyrosines 
in muscle tissue compared with all other tissues, we next analysed 
all identified proteins carrying tyrosine phosphorylations in rat 
tissues with regards to their involvement in biological processes. 
As evident from the hierarchical clustering figure presented in 
Fig. 5d there are two major processes contributing to the different 
phosphotyrosine pattern of muscle tissue, namely glycogenoly-
sis and muscle contraction. Although muscle contraction is also a 
crucial part of cardiac function, the majority of phosphotyrosines 
involved in skeletal muscle contraction are not present in the heart 
and vice versa. To investigate whether proteins involved in muscle 
contraction in human skeletal muscle are also tyrosine phosphor-
ylated, we next investigated protein–protein interaction networks of 
tyrosine-phosphorylated proteins identified in human skeletal mus-
cle biopsies (Fig. 5e). As evident from the figure proteins involved 
in the contractile machinery are indeed tyrosine phosphorylated. 
Receptor tyrosine kinases are the major class of enzymes responsible 
for tyrosine phosphorylation in mammalian cells41, but we do not 
identify any receptor tyrosine kinases in the skeletal muscle samples. 
However, we do identify tyrosine-phosphorylated peptides from the 
activation loop (T-loop) of the kinase domains of both the cyto-
plasmic tyrosine kinases Yes/Src/Lck/Fyn (LIEDNEYpTAR) and 
Lyn/Hck (VIEDNEYpTAR) as well as of the dual-specificity tyro-
sine-regulated kinase DYRK1A/B (IYQYpIQSR and IYQYpIQSpR). 
Both of these kinase classes phosphorylate their substrates on tyro-
sine residues and phosphorylation of their activation loops are 
a proxy for their activation state in the skeletal muscle42, which 
suggest that these kinases are involved in regulation of the skel-
etal muscle tyrosine phosphoproteome. For the human skeletal 
muscle samples, we also identify multiple haemoglobin subunits 
with tyrosine phosphorylations, which can be explained by the lack 
of perfusion in the human muscle sample preparation. To further 
investigate the metabolic process with high levels of phosphotyro-
sines involving glucose metabolism, we delineated the pathway of 
glycogenolysis in Fig. 6. Glycogenolysis predominantly occurs in 
muscle cells as a means to produce energy, and it is highly regulated 
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dependent on the metabolic state. However, it also occurs in the 
liver where glucose is produced and released into the blood to 
maintain adequate glucose levels. To survey differences in glycog-
enolysis among muscle and liver tissues, we highlighted the phos-
phoproteins involved in the pathway in the two tissues along with 
the phosphorylation sites detected. As evident from the figure, 
the phosphoproteins involved in the pathway were well covered 
for both tissues, but we only identified a large proportion of tyro-
sine-phosphorylated proteins in muscle. Again, the involvement of 
phosphotyrosines appears to be a common phenomenon of phys-
iological relevance, as it was observed in rat as well as in human 
skeletal muscle. This is also supported by the recent findings of tyro-
sine phosphorylation sites as critical regulators of glycolytic pathway 
enzymes like lactate dehydrogenase A43 and pyruvate dehydroge-
nase kinase 1 (ref. 44) for cancer cell metabolism. As most signal-
ling networks rely on sequential and coordinated phosphorylation 
of specific pathway proteins, it is intriguing that tyrosine phosphor-
ylation is much more prevalent in muscle compared with liver, thus 
suggesting that glycogenolysis is likely regulated by tyrosine kinases 
in muscle, whereas this is not the case in liver.
Proline-directed kinases phosphorylate transcription factors. 
Proline-directed kinases, such as CDKs and MAPKs, have some of 
the best-described amino-acid sequence motifs, and thus we next 
focused on all the proline-mediated phosphorylation sites we have 
identified. We compared the presence of proline-mediated phos-
phorylation sites among different cellular compartments, focusing 
on the extracellular space, the plasma membrane, the cytoplasm, the 
endoplasmic reticulum and golgi as well as the nucleus. The high-
est abundance of proline-mediated phosphorylation sites is identi-
fied in the nucleus, where we observe both the greatest prevalence 
frequency and the greatest number of proline-mediated phosphor-
ylation sites (Fig. 7a). To investigate the biological underpinnings 
for this, we focused on two classes of proteins particular for the 
nucleus, namely protein kinases and transcription factors (Fig. 7b). 
We used a similar approach as presented by Rigbolt et al.45 to 
extract transcription factors from our data set based on annotated 
DNA-binding protein domains (HLH, HMG-box, bZIP, Forkhead 
and Homeobox). The prevalence of proline-directed phosphoryla-
tion sites of protein kinases is similar to that of all identified phos-
phorylation sites, whereas the prevalence is significantly greater for 
transcription factors. The fraction of phosphorylation sites that are 
proline-mediated becomes even greater when we focus on tissue-
specific phosphorylation sites on transcription factors. Analysing 
the amino-acid sequences of the proline-mediated phosphorylation 
sites in the nucleus, it is apparent that these are generally mediated 
by CDK kinases by conforming to the proline-directed motif with 
basophilic residues in the  + 2 or  + 3 position (Fig. 7c). However, ana-
lysing amino-acid sequences of all phosphorylation sites identified 
on transcription factors reveals an apparent MAP kinase sequence 
logo [P-X-S/T-P] (Fig. 7d), consistent with previous reports on 
widespread transcriptional regulation by MAP kinases46. Thus, in 
general proline-directed phosphorylation is highly abundant in the 
nucleus, and it is primarily mediated by CDK kinases, but proline-
directed phosphorylation of transcription factors are mediated by 
MAP kinases. The tissue-specific proline-directed phosphorylation 
sites on transcription factors are listed in the table in Supplementary 
Fig. S11.
Discussion
Here we show that an efficient method for tissue protein extrac-
tion in combination with phosphopeptide enrichment and high- 
resolution tandem MS can quantify an impressive amount of 
phosphopeptides and protein phosphorylation sites from tissue 
samples in a limited time. The method was validated by the clus-
tering profile of the phosphopeptides in specific tissues and by 
reproducing the tyrosine phosphorylation pattern found in rat and 
human skeletal muscle samples.
From a scientific perspective, the data set we report herein pro-
vides a useful resource for future hypothesis-driven exploration of 
tissue-specific variations in phosphorylation-mediated regulation 
of proteins; thereby also presenting the opportunity to identify new 
cellular targets for regulatory phosphorylation events. Furthermore, 
with the increasing evidence manifesting involvement of dys-
functional signalling cascades, not only in many types of cancer, 
but also in diabetes and neuropsychiatric disorders, the need for 
unravelling signalling cascades in the appropriate tissues are under-
scored. From the data presented it is evident that there are major 
differences in the phosphorylation patterns across tissues, and 
accordingly it is apparent that for understanding the molecular 
mechanisms underlying disease signalling pathways, it is crucial to 
investigate the components in the appropriate tissue with site spe-
cificity. To do this successfully, it is a prerequisite that reliable and 
comprehensive methods are developed that allow for such inves-
tigations. In the future, it will furthermore be beneficial if tissue 
samples from patients can be analysed as a mean to evaluate which 
medical treatment is most appropriate. From cancer patients, it is for 
instance known that there is great variation in how well the patients 
respond to different treatments, likely due to patient-specific differ-
ences in affected steps of the signalling pathways. As the method 
presented herein is a rapid procedure that only requires a few hours 
of LC-MS/MS analysis time per tissue, thus making it much simpler 
and time-preserving compared with previously presented methods, 
it provides a promising platform for standardizing screening of 
tissue phosphoproteomes.
Methods
Sample preparation and peptide extraction. The study was carried out following 
approved national regulations in Denmark and with animal experimental licence 
granted by the Animal Experiments Inspectorate, Ministry of Justice, Denmark. 
Four Sprague Dawley rats (Crl:SD, male, 350 g, Charles River, Germany) were 
anaesthetized with isoflurane and perfused (1½ min, 30 ml min − 1) with isotonic 
saline-containing protease inhibitors (0.120 mM EDTA, 14 µM aprotinin, 0.3 nM 
valine-pyrrolidide and, Roche Complete Protease Inhibitor tablets (Roche), 
pH = 7.4) before being decapitated. The organs were quickly dissected, and except 
for the brain they were all snap frozen in 2-methylbutane followed by heat inactiva-
tion (Denator T1 Heat Stabilizor, Denator, Gothenburg, Sweden). After dissection, 
the brain was heated to 95 °C (by a Denator T1 Heat Stabilizor), subdissected into 
cerebellum, cortex and brainstem. Non-heparinized trunk blood was collected 
from another group of four rats by decapitation.
Human muscle biopsies were obtained from the musculus vastus lateralis  
in three healthy volunteers during resting conditions with a needle modified for 
suction under local anaesthetics using the Bergström technique47. The study-part 
including human volunteers conformed to the Helsinki II declaration and was 
approved by the relevant local ethics committee (Ethical approval number H-A-2009-
016 for Region Hovedstaden, Denmark). The biopsy specimens were rapidly trans-
ferred to liquid nitrogen (within 5 s), and thereafter stored at –80 °C until analysed.
The tissues were transferred to a urea solution containing phosphatase inhibi-
tors (6 M urea/2 M thiourea, 10 mM HEPES, 1 mM ortho-vanadate, 5 mM sodium 
flouride, 5 mM β-glycerophosphate, pH = 8.0) in 5 µl extraction buffer per mg 
tissue (wet weight) and homogenized by ceramic beads using 1–6 homogenization 
steps of 20 s at 5,000 r.p.m. (Precellys 24, Bertin Technologies, France) followed by 
micro-tip sonication on ice. The homogenized samples were centrifuged (20 min, 
16,000g, 4 °C) and the supernatants were retrieved.
Protein digestion. Samples were reduced (final concentration 1 mM dithiothreitol, 
750 r.p.m., 30 min), and alkylated (final concentration 5.5 mM chloroacetamide, 
750 r.p.m., 20 min in darkness). Protein concentrations were measured (Quick Start 
Bradford Dye Reagent X1, Bio-Rad) and 10 mg protein per tissue was digested with 
50 µg endoproteinase Lys-C (Wako) (750 r.p.m., 3 h). The samples were diluted with 
25 mM ammonium bi-carbonate to lower the urea concentration below 2 M, and 
then further digested with 50 µg modified trypsin (Sequencing grade, Promega; 
750 r.p.m., 8 h). Trypsin digestion was quenched by lowering pH ~2 with trifluoro-
acetic acid (TFA). Samples were centrifuged (20 min, 16,000g) and supernatants 
were desalted and concentrated on Sep-Pack C18 Cartridges (Waters).
Enrichment of phosphopeptides. The phosphopeptides in the samples were 
enriched using Titanium dioxide (TiO2) beads essentially as described in Olsen  
et al.16 A stock solution of 20 mg TiO2 beads (GL Sciences, Japan) per 100 µl  
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2,5-dihydroxybenzoic acid (DHB; 0.02 g DHB per ml 80% acetonitrile (MeCN), 
0.5% acetic acid (AcOH)) were mixed for 15 min, 5 µl of this was added to the sam-
ples, which were then incubated with gentle rotation for 15 min. The TiO2 beads 
were quickly spun down and the supernatants were transferred to new Eppendorf 
tubes and incubated with a second round of TiO2 beads as described above. The 
beads were washed with 100 µl of 5 mM KH2PO4, 30% MeCN, 350 mM KCl fol-
lowed by 100 µl of 40% MeCN, 0.5% AcOH, 0.05% TFA and then re-suspended 
in 50 µl of 80% MeCN, 0.5% AcOH. The beads were loaded onto in-house packed 
C8 STAGE tips in 200 µl pipette tips preconditioned with 80% MeCN, 0.5% AcOH 
and washed once with the same buffer, and eluted with 2×10 µl 5% ammonia and 
2×10 µl 10% ammonia, 25% MeCN. Ammonia and organic solvents were evapo-
rated using a vacuum centrifuge, and the peptides were acidified in 1% TFA, 5% 
MeCN and loaded onto in-house packed C18 STAGE tips48 preconditioned with 
20 µl MeOH, 20 µl 80% MeCN, 0.5% AcOH, 2×20 µl 1% TFA, 3% MeCN. Stage tips 
were washed with 2×20 µl of 8% MeCN, 0.5% AcOH, and 1×50 µl of 0.5% AcOH.
LC-MS/MS analysis. Peptides were eluted into 96-well microtiter plates with 
2×10 µl of 40% MeCN, 0.5% AcOH, organic solvents were removed in a vacuum 
centrifuge, and the peptides were reconstituted in 2% MeCN, 0.5% AcOH, 0.1% 
TFA. A volume of 5 µl of this eluate was analyzed by online reversed-phase C18 
nanoscale liquid chromatography tandem MS on an LTQ-Orbitrap Velos mass 
spectrometer (Thermo Electron, Bremen, Germany) using a top10 HCD fragmen-
tation method as described previously27. The LC-MS analysis was performed with 
a nanoflow Easy–nLC system (Proxeon Biosystems, Odense, Denmark) connected 
through a nano-electrospray ion source to the mass spectrometer. Peptides were 
separated by a linear gradient of MeCN in 0.5% acetic acid for 180 min in a 15-cm 
fused-silica emitter in-house packed with reversed-phase ReproSil-Pur C18-AQ 
3 µm resin (Dr Maisch GmbH, Ammerbuch-Entringen, Germany). Full-scan MS 
spectra were acquired at a target value of 1e6 and a resolution of 30,000, and the 
HCD-MS/MS spectra were recorded at a target value of 5e4 and with resolution  
of 7,500 using a normalized collision energy of 40%.
Phosphopeptide quantification and identification. Raw MS files were processed 
using the MaxQuant software49 (ver.1. 0.14.7, Max-Planck Institute of Biochem-
istry, Department of Proteomics and Signal Transduction, Munich) by which the 
precursor MS signal intensities were determined and HCD-MS/MS spectra were 
deisotoped and filtered such that only the ten most abundant fragments per 100-
m/z range were retained. Phosphoproteins were identified using the Mascot search 
algorithm (http://www.matrixscience.com) by searching all MS/MS spectra against 
a concatenated forward/reversed version of rat and mouse International Protein 
Index v.3.37 protein sequence database supplemented with protein sequences of 
common observed contaminants such as human keratins and porcine trypsin. The 
HCD-MS/MS spectra were searched with fixed modification of Carbamidomethyl-
Cysteine and we allowed for variable modifications of oxidation (M), acetylation 
(protein N-term), Gln- > pyro-Glu, and phosphorylation (STY). Search param-
eters were set to an initial precursor ion tolerance of 7 p.p.m., MS/MS tolerance 
at 0.02 Da and requiring strict tryptic specificity with a maximum of two missed 
cleavages. Label-free peptide quantification and validation was performed in the 
MaxQuant software suite49,50. Phosphopeptides were filtered based on Mascot 
score, PTM (Andromeda) score51, precursor mass accuracy, peptide length and 
summed protein score to achieve an estimated false discovery rate < 0.01 based on 
the forward and reversed identifications52. The minimum required peptide length 
was set to six amino acids. We required a minimum Mascot score of 10 and a 
minimum Andromeda score of 25.
Data analysis and presentation. Data analysis was done using Microsoft  
Office Excel and Perseus53 (Max-Planck Institute of Biochemistry, Department  
of Proteomics and Signal Transduction, Munich) software. Tissue figures were  
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produced using Servier Medical Art (http://www.servier.com). Hierarchical 
clustering was performed in Persues using Euclidian distance and average linkage 
clustering. GO enrichment analysis was alike performed in Perseus, either for  
a cluster of tissue-specific proteins or for phosphoproteins present in either  
one or all tissues. The whole quantified phosphoprotein data set was used as  
reference data set and P-values were calculated using the Benjamini–Hochberg 
method.
Linear kinase motif analysis. We analysed the frequency of particular amino 
acids in the proximity of phosphorylation sites by looking for specific kinase  
phosphorylation motifs. To avoid noise in the analysis from motifs without  
unambiguously assigned phosphorylation sites, we used only sites with a localiza-
tion probability  > 0.75 and ∆PTM score  > 5 (class 1) for the analysis. To search  
for over-represented motifs, we used sequence windows of  ± 6 residues adjacent 
to all serine and threonine phosphorylation sites and matched these against ten 
known linear protein kinase motifs (http://www.phosida.com) representing PKA, 
AKT, PKD, CAMK2, CHEK, CK2, PLK, CDK, ERK and ATM/ATR kinases, as  
well as proline-directed substrate sites. The frequency of all kinase motifs were 
extracted for each tissue individually and compared with the median occurrence  
in all 14 tissues. To identify tissue enriched as well as under-represented motifs,  
we calculated the percentage difference between the individual tissues and the 
median occurrence for each kinase motif and clustered this matrix in Perseus  
using correlation-based two-way hierarchical clustering.
Sequence pattern analysis. We performed sequence pattern analysis using  
iceLogo54 with percentage difference as scoring system and a P-value cut-off of  
0.05. For details see Supplementary Data 3.
CPR PTM resource. The CPR PTM Resource (http://cpr1.sund.ku.dk/cgi-bin/
PTM.pl) is a web-based data repository that integrates all of the high-confidence 
in-vivo post-translational modifications sites such as site-specific phosphorylation 
that we have identified by MS-based proteomics in different tissue samples from 
various species. It is based on a MySQL database and developed with the Perl/CGI 
language. Modified proteins can be visualized based on their Uniprot identifiers. 
For each modified site in a protein, we list matching kinase motifs and use the 
Reflect (http://reflect.cbs.dtu.dk/index.html) service to add additional information 
about the modified proteins. Selected screen shots from the website are displayed 
in Supplementary Fig. S12.
Protein–protein interaction networks. Protein–protein interaction networks were 
built using a previously described up to date interaction network of quality control-
led predicted and measured human protein interactions (InWeb, Lage  
et al.34). Detailed description is provided in Supplementary Data 4. 
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